Healthcare Services

A key trend shaping the Cannabis Pharmaceuticals Market involves the Advancing Medical Cannabis Production To Meet Global Demand

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Cannabis Pharmaceuticals Market During The Forecast Period 2026–2030?

The cannabis pharmaceuticals market has experienced significant expansion over recent years. It is anticipated to increase from $9.43 billion in 2025 to $14.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 56.3%. The growth observed in prior periods stemmed from heightened recognition of the therapeutic advantages of cannabinoids, the increased distribution of medical cannabis prescriptions, the emergence of early cannabis-derived medications, the expansion of hospital-based pain management initiatives, and regulatory approvals granted to specific cannabis pharmaceutical products.

The cannabis pharmaceuticals market is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $85.68 billion, exhibiting a compound annual growth rate (CAGR) of 55.3%. The projected growth during this period is driven by increasing investments in cannabis drug clinical trials, a rising demand for standardized cannabinoid formulations, the broadening of neurological and oncology applications, a growing adoption of cannabis pharmaceuticals in hospitals, and an increasing regulatory harmonization across various markets. Prominent trends for the forecast period include the increasing development of prescription-grade cannabis medications, a heightened focus on clinical validation and trials, expanding use in neurological and pain disorders, the enlargement of regulated pharmaceutical pipelines, and an enhanced emphasis on dosage precision.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp

Which Major Factors Are Driving The Expansion Of The Cannabis Pharmaceuticals Market?

The increasing occurrence of epilepsy is anticipated to propel the cannabis pharmaceuticals market. Epilepsy is a neurological disorder defined by repeated, unprovoked seizures stemming from irregular electrical brain activity. The growth in epilepsy cases can be attributed to enhanced diagnostic methods, greater public awareness, and improved reporting, in addition to potential environmental, genetic, and lifestyle influences. Cannabis pharmaceuticals offer potential in managing epilepsy by utilizing cannabinoids such as CBD to lessen the frequency and intensity of seizures for patients who do not respond well to conventional anti-epileptic medications. For example, according to the World Health Organization, a Switzerland-based global health agency, the worldwide number of individuals living with epilepsy had reached approximately 50 million in 2024, as reported in February 2024. Consequently, the rising incidence of epilepsy is driving the expansion of the cannabis pharmaceuticals market.

What Market Segments Are Evaluated Within The Cannabis Pharmaceuticals Market?

The cannabis pharmaceuticals market covered in this report is segmented –

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids

2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists

What Industry Trends Are Redefining The Cannabis Pharmaceuticals Market?

Key players in the cannabis pharmaceuticals market are concentrating on creating groundbreaking products, such as sophisticated medical cannabis formulations, to manage diverse medical conditions and elevate patient results. Sophisticated medical cannabis formulations denote specially engineered cannabis-derived products tailored for therapeutic application, containing precise amounts of cannabinoids like THC and CBD. For example, in April 2024, Canexis Pharma AG, a Switzerland-based pharmaceutical entity, secured manufacturing and narcotics licenses from Swissmedic for cannabis pharmaceuticals. These authorizations permit the company to produce top-tier medicinal active ingredients sourced from CBD and THC. This progress allows Canexis to address the escalating demand for medical cannabis both domestically in Switzerland and internationally. By acquiring these licenses, the company illustrates its conformity with rigorous regulatory benchmarks, thereby bolstering its standing and potential contribution to the quickly developing medical cannabis market.

Who Are The Top Market Participants Influencing The Cannabis Pharmaceuticals Market?

Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.

Read the full cannabis pharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

Which Region Currently Holds The Largest Share Of The Cannabis Pharmaceuticals Market?

North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cannabis Pharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20723&type=smp

Browse Through More Reports Similar to the Global Cannabis Pharmaceuticals Market 2026, By The Business Research Company

Cannabis Capsule Global Market Report

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Recreational Cannabis Global Market Report

https://www.thebusinessresearchcompany.com/report/recreational-cannabis-global-market-report

Plant Extracts Global Market Report

https://www.thebusinessresearchcompany.com/report/plant-extracts-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795